Skip to main content
. 2020 Jan 20;10(6):2453–2462. doi: 10.7150/thno.42981

Scheme 1.

Scheme 1

Metastable-phase manganese sulfide nanotheranostics (MnS@BSA) for tumor pH-responsive traceable hydrogen sulfide (H2S) gas therapy primed chemodynamic therapy (CDT) of cancer. The MnS@BSA can be degraded in response to the mildly acidic tumor microenvironment, releasing H2S for gas therapy and Mn2+ for magnetic resonance imaging (MRI) and CDT of cancer.